• Media releases
  • Features
  • Gallery
  • Quick facts
  • Contact
  • About Medibank
  • Investor Centre
  • ASX Releases

    Macquarie Australia Conference and Medibank letter to shareholders

    Craig Drummond Macquarie Australia Conference

    CEO Craig Drummond gave an update to the market in a presentation to the Macquarie Australia Conference, and a letter to shareholders was published on the ASX - a copy of which is below.

    Dear Shareholders,

    As your Chairman and CEO, we write to you during what is a challenging time.

    There is nothing normal about the way we have all been living and working throughout the COVID-19 pandemic – it has significantly affected us all and the health and economic impacts have been severe.

    Our focus has been on supporting our people, customers and the community during this time, and as shareholders of this company we wanted to update you on how we have responded to COVID-19 and reiterate that we remain strongly positioned within the broader healthcare industry.

    We are supporting our customers
    Among our customers, we have seen the majority hold onto their insurance for the peace of mind that it provides.

    But we understand that our customers have been confronted with enormous uncertainty and profound stress, with many Australians already facing the stark reality of losing their jobs. Nothing could have prepared Australian households for this.

    That’s why we have introduced a number of measures to assist our customers, which include:

    Initial customer support package valued at more than $50 million
    Regardless of an existing customer’s level of hospital cover, Medibank and ahm are paying benefits towards chest, heart, lung and kidney hospital admissions, including those related to COVID-19, benefiting 1 million customers. Eligible customers also have the option to suspend their cover or access some relief on their premiums. We have seen just over 1% of customers suspend their policies which is well within our expectations.

    Premium increases postponed
    Medibank and ahm postponed premium increases for 6 months for all customers, until October 2020. This is approximately a $120 million saving for customers.

    COVID-19 Health Assist
    Medibank has brought together its broad range of health services to develop COVID-19 Health Assist, a program of customised health and wellbeing support for customers throughout the COVID-19 pandemic.

    Extended access to telehealth
    Medibank and ahm customers can now claim for a range of consultations delivered by phone or video (otherwise known as telehealth) as part of their Extras cover. We’ve added 7 additional Extras services such as psychology, physiotherapy and dietetics to telehealth during COVID-19.

    We are committed to returning any permanent COVID-19 related benefits, in excess of the current package outlined above, to our customers once they are known savings.

    We’ve also been focused on supporting the broader community during this time. That’s why we donated $5 million to Beyond Blue for their new COVID-19 mental wellbeing and support service and we also launched a free online program for all Australians offering work out videos, cooking demonstrations and guided meditations for people to do from the comfort of their own home.

    Our long-term strategy is unchanged
    Medibank’s strategy is the right strategy to navigate through this health and economic crisis. The Executive Leadership Team remains focused on differentiating our private health insurance business through leveraging our dual brand strategy while also transforming into a broader healthcare company.

    The health sector in particular has undergone enormous change and its response to COVID-19 has been extraordinary. The sector has shown that it can adapt, change and collaborate where needed. That said, reform is just as important as it ever was and we will continue to advocate for our customers, particularly in the area of affordability.

    Outlook and dividends
    You may be asking yourselves what impact COVID-19 will have on Medibank's performance and shareholder dividends.

    What we’ve told the market today in an update, is that despite the challenging market conditions, there is no overall change to our FY20 financial outlook. Medibank’s FY20 dividend, as per usual, will be determined by the board in mid-August when it is announced as part of our financial results. You can read more about our update on our investor centre.

    And you’ll be pleased to know that when it comes to our costs, we remain focused on our productivity program, with our management expenses expected to be approximately $545 million (comfortably below last year’s $560.1 million).

    Looking ahead
    The longer-term impacts of COVID-19 are less certain. The affordability of private health insurance has been a challenge for many Australians over recent years and uncertainty over the speed at which the economy can recover from COVID-19 will likely keep affordability at the forefront of issues we face.

    However, private health insurance will continue to offer customers choice in who, how, when and where their healthcare is provided and will arguably be even more important as the public healthcare system seeks to recover post COVID-19.

    Rest assured, Medibank remains strongly positioned in the broader health industry. Our capital position remains strong and our balance sheet is debt free.

    We extend our thanks to the Executive Leadership Team and Medibank’s 4,000 employees who have done an extraordinary job in helping your company navigate COVID-19.

    And lastly, we thank you as shareholders for your ongoing support and hope that you are proud of how your company has responded to COVID-19.

    Best wishes and stay safe,
    Elizabeth Alexander AO and Craig Drummond
    Chairman and CEO

    Shareholder letter FY20 outlook update

    For a complete list of all ASX announcements, please visit our Investor Centre.

    Keep reading